SCHEMBL5209045

SCHEMBL5209045

Cc1ccc(C(=O)O)c(NC(=O)Cc2c[nH]c3ccc(Br)cc23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.49
MTNR1A P48039 2/20 0.47
MTNR1B P49286 2/20 0.47
SIGMAR1 Q99720 1/20 0.46
MAPT P10636 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
IDO1 P14902 1/20 0.44
GPR84 Q9NQS5 1/20 0.44
NR4A2 P43354 1/20 0.44
ICMT O60725 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5210504 0.87 TSHR (0.56) MTNR1AMTNR1BMAPTNPSR1GPR84
SCHEMBL5210851 0.86 MAPT (0.60) CDK2MAPTNPSR1MEN1KMT2A
SCHEMBL5207887 0.85 KDM4E (0.60) MTNR1AMTNR1BSIGMAR1MAPTMEN1
SCHEMBL5206707 0.84 ICMT (0.53) MTNR1AMTNR1BMAPTNPSR1ICMT
SCHEMBL5211211 0.81 HTR1D (0.48) MAPTNPSR1ICMTPOLBSMN1; SMN2
SCHEMBL5213952 0.81 ICMT (0.47) MAPTNPSR1MEN1KMT2AICMT
SCHEMBL5214070 0.81 PPARG (0.57) MAPTMEN1KMT2APOLBSMN1; SMN2
SCHEMBL5207800 0.80 ICMT (0.51) CDK2MTNR1AMTNR1BSIGMAR1MEN1
SCHEMBL5213599 0.79 ICMT (0.61) MAPTNPSR1MEN1KMT2AICMT
SCHEMBL5208637 0.79 ICMT (0.49) CDK2MAPTMEN1KMT2AICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288564-B2 Indole derivatives GLAXO GROUP LIMITED (GB) 2007-10-30 US claimed
US-7288564-B2 Indole derivatives GLAXO GROUP LIMITED (GB) 2007-10-30 US disclosed
EP-1343757-B1 INDOLE DERIVATIVES GLAXO GROUP LTD (GB) 2007-02-14 EP disclosed
US-20040092569-A1 Indole derivatives GLAXO GROUP LIMITED (GB) 2004-05-13 US disclosed
EP-1343757-A1 INDOLE DERIVATIVES GLAXO GROUP LIMITED (GB) 2003-09-17 EP disclosed
WO-2002050031-A1 INDOLE DERIVATIVES GLAXO GROUP LIMITED (GB) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092569-A1 Indole derivatives PTGER4, PTGER1, TRPV4 CDK2 1169/4885MTNR1A 48/4885MTNR1B 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.